PD Dr. Matthias Rübner

Department of Obstetrics and Gynaecology Medizinische Fakultät

Impact of CCND1 amplification on the prognosis of hormone receptor–positive, HER2-negative breast cancer patients—correlation of clinical and pathological markers (2024) Hanf D, Fasching P, Gaß P, Beckmann M, Hack C, Heindl F, Häberle L, et al. Journal article Correlation of RANK and RANKL with mammographic density in primary breast cancer patients (2024) Wunderle M, Heindl F, Behrens A, Häberle L, Hack C, Heusinger K, Hübner H, et al. Journal article Quality-Assured Analysis of PIK3CA Mutations in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Tissue: A Story About the Need for Proficiency Testing for High-Quality Molecular Biomarker Reporting in Precision Medicine (2024) Schmidt C, Stöhr R, Dimitrova L, Beckmann M, Rübner M, Fasching P, Denkert C, et al. Journal article Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer (2024) Heger L, Heidkamp GF, Amon L, Nimmerjahn F, Bäuerle T, Maier A, Erber R, et al. Journal article Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry (2023) Mueller SH, Lai AG, Valkovskaya M, Michailidou K, Bolla MK, Wang Q, Dennis J, et al. Journal article Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows (2023) Lehle S, Emons J, Hack C, Heindl F, Hein A, Preuß C, Seitz K, et al. Journal article Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study (2023) Hack C, Maass N, Aktas B, Kümmel S, Thomssen C, Wolf C, Kolberg HC, et al. Journal article Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy (2023) Pöschke P, Fasching P, Adler W, Rübner M, Beckmann M, Hack C, Heindl F, et al. Journal article Ex Vivo Chromosomal Radiosensitivity Testing in Patients with Pathological Germline Variants in Breast Cancer High-Susceptibility Genes BReast CAncer 1 and BReast CAncer 2 (2023) Zuhair Kassem T, Wunderle M, Kuhlmann L, Rübner M, Hübner H, Hoyer J, Reis A, et al. Journal article Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases (2023) Figlioli G, Billaud A, Wang Q, Bolla MK, Dennis J, Lush M, Kvist A, et al. Journal article